相关实验视频
Updated: Feb 7, 2026
06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
9.7K
用VEGF模拟修改的双功能纳米系统,用于针对心肌梗塞的向药物输送
Maisituremu Tuerhan1, Hailan Tian1, Qinyi Lu1
1Department of Pharmacology, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
ACS applied bio materials
|February 5, 2026
概括
这项研究开发了一种新型纳米药物 (A-M@P-Q),可促进血管再生和氧化 (NO) 生产,用于治疗心肌缺血/再生 (I/R) 损伤,显示出有前途的治疗效果和安全性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 心血管研究研究心血管研究
背景情况:
- 心肌缺血/反 (I/R) 损伤仍然是一个重大的临床挑战.
- 目前的疗法在促进有效的组织修复和再生方面存在局限性.
- 需要创新的策略,将血管再生与氧化物 (NO) 等关键信号通路的调节结合起来.
研究的目的:
- 设计一种双功能纳米药物 (A-M@P-Q) 用于精确治疗心肌I/R损伤.
- 将血管再生 (通过VEGFR向) 和NO调制 (通过l-阿尔金因) 整合到一个治疗剂中.
- 在心肌I/R损伤的临床前模型中评估A-M@P-Q的疗效和安全性.
主要方法:
- 合成A-M@P-Q纳米药物使用半孔多多巴胺协调,功能化与VEGFR向 (QK) 和装载l-arginine.
- 在实验室验证使用细胞缺氧/再生氧化 (H/R) 模型来评估NO产量,活性氧物种 (ROS) 水平,线粒体功能,亡和血管生成.
- 用小鼠心肌I/R模型进行体内研究,包括治疗验证,生物分布跟踪和生物安全性评估.
主要成果:
- A-M@P-Q证明了双重治疗疗效,通过VEGFR2激活促进血管生成并恢复NO平衡.
- 在体外,A-M@P-Q增强了NO的产生,减少了ROS,改善了线粒体功能,抑制了亡,并在H/R治疗的内皮细胞中促进了血管生成.
- 在体内,A-M@P-Q增强了VEGFR2酸化和NO度,降低了细胞亡,并促进了肌动脉I/R小鼠的早期血管生成,在心脏病发作区域有针对性的积累和微不足道的毒性.
结论:
- 双功能纳米系统A-M@P-Q为心肌I/R损伤提供了一种协调的治疗方法.
- 这一策略将新血管化与NO促进同步用于针对性心肌修复.
- A-M@P-Q代表了一种在临床上可转换的I/R损伤管理策略.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
1.9K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.9K
01:16Drug Delivery: Overview
879
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
879
01:18Drug Delivery: Enteral Route
1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
01:29Drug Delivery: Parenteral Route
1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
01:26Targets for Drug Action: Overview
10.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.4K
02:43Peptide Bonds
83.2K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.2K